Trichotillomania: a treatment overview.
Voth
David
D
D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003987:Dibenzothiazepines / Q000627:therapeutic use; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D007099:Imipramine / Q000627:therapeutic use; D016651:Lithium Carbonate / Q000627:therapeutic use; D009730:Nursing Assessment; D009743:Nursing, Practical / Q000379:methods; D000077152:Olanzapine; D011569:Psychiatric Status Rating Scales; D000069348:Quetiapine Fumarate; D012307:Risk Factors; D018967:Risperidone / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D015899:Tomography, Emission-Computed, Single-Photon; D014256:Trichotillomania / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D015283:Citalopram; D003987:Dibenzothiazepines; D016666:Fluvoxamine; D006919:Hydroxyzine; D007099:Imipramine; D016651:Lithium Carbonate; D000077152:Olanzapine; D000069348:Quetiapine Fumarate; D018967:Risperidone; D017367:Selective Serotonin Reuptake Inhibitors